Breaking News Instant updates and real-time market news.

LNDC

Landec

$11.03 /

+0.01 (+0.09%)

07:34
09/03/19
09/03
07:34
09/03/19
07:34

Landec initiated with an Outperform at Barrington

Barrington analyst Michael Petusky started Landec with an Outperform rating and $13 price target. While Curation Foods has generated most of Landec's revenue the past few years, meaningful profitability has been elusive, Petusky tells investors in a research note. However, he believes the company is in the process of turning this piece of its business around.

LNDC Landec
$11.03 /

+0.01 (+0.09%)

08/23/19 DA Davidson
Landec initiated with a Buy at DA Davidson
08/23/19 DA Davidson
Landec initiated with a Buy at DA Davidson
05/23/19 Lake Street
Landec price target lowered to $12 from $16 at Lake Street
04/08/19
Landec downgraded to Neutral at Roth Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Momenta says CSL plans to introduce M230 Phase 1 program this year » 07:31
08/10/20
08/10
07:31
08/10/20
07:31
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

Momenta's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Recommendations
Albemarle price target raised to $87 from $65 at Truist » 07:30
08/10/20
08/10
07:30
08/10/20
07:30
ALB

Albemarle

$84.42 /

+1.12 (+1.34%)

Truist analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

07/27/20
Fly Intel: Top five analyst downgrades
07/27/20 Berenberg
Albemarle downgraded to Sell following rally off lows at Berenberg
07/27/20 Berenberg
Albemarle downgraded to Sell from Hold at Berenberg
06/26/20
Fly Intel: Top five analyst upgrades
ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

Hot Stocks
Momenta expects Phase 2 study of M254 to commence in 2021 » 07:30
08/10/20
08/10
07:30
08/10/20
07:30
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

Patient enrollment is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Hot Stocks
Momenta to initiate Phase 3 nipocalimab study in 1Q21 » 07:30
08/10/20
08/10
07:30
08/10/20
07:30
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

In June 2020, Momenta…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Hot Stocks
Momenta sees 2020 non-GAAP operating expenses $200M-$220M  07:29
08/10/20
08/10
07:29
08/10/20
07:29
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

 
ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Earnings
Momenta reports Q2 EPS (48c), consensus (39c) » 07:28
08/10/20
08/10
07:28
08/10/20
07:28
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

Reports Q revenue $6.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Downgrade
PRA Health downgraded to Underperform from Buy at BofA » 07:27
08/10/20
08/10
07:27
08/10/20
07:27
PRAH

PRA Health

$106.54 /

-2.21 (-2.03%)

BofA analyst Juan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRAH PRA Health
$106.54 /

-2.21 (-2.03%)

PRAH PRA Health
$106.54 /

-2.21 (-2.03%)

07:27 Today BofA
Correction: PRA Health double downgraded to Underperform from Buy at BofA
07/27/20 SunTrust
SunTrust raises price targets on select late-stage CROs
05/04/20 SunTrust
PRA Health price target raised to $103 from $89 at SunTrust
05/01/20 William Blair
PRA Health downgraded to Market Perform from Outperform at William Blair
PRAH PRA Health
$106.54 /

-2.21 (-2.03%)

  • 04
    Sep
Hot Stocks
Chimerix announces expected upcoming milestones » 07:27
08/10/20
08/10
07:27
08/10/20
07:27
CMRX

Chimerix

$3.42 /

+0.18 (+5.56%)

Completion of NDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

05/21/20 JonesTrading
Chimerix initiated with a Buy at JonesTrading
CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

Recommendations
Apple price target raised to $515 from $475 at Wedbush » 07:26
08/10/20
08/10
07:26
08/10/20
07:26
AAPL

Apple

$444.41 /

-10.98 (-2.41%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

07:02 Today KeyBanc
Survey indicates strengthening recovery in Apple iPhone sales, says KeyBanc
08/06/20 KeyBanc
Synaptics upgraded to Overweight from Sector Weight at KeyBanc
08/06/20 Barclays
SiTime price target raised to $75 from $50 at Barclays
08/05/20
Fly Intel: Top five analyst downgrades
AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

Hot Stocks
Chimerix expexts cash balance of approx. $70M at end of 2020 » 07:26
08/10/20
08/10
07:26
08/10/20
07:26
CMRX

Chimerix

$3.42 /

+0.18 (+5.56%)

Chimerix's balance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

05/21/20 JonesTrading
Chimerix initiated with a Buy at JonesTrading
CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

Initiation
BlueCity initiated with a Buy at Loop Capital » 07:26
08/10/20
08/10
07:26
08/10/20
07:26
BLCT

BlueCity

$15.11 /

+0.02 (+0.13%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 08
    Jul
BLCT BlueCity
$15.11 /

+0.02 (+0.13%)

Earnings
Chimerix reports Q2 EPS (16c), consensus (17c) » 07:26
08/10/20
08/10
07:26
08/10/20
07:26
CMRX

Chimerix

$3.42 /

+0.18 (+5.56%)

Reports Q2 revenue $1.4M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

05/21/20 JonesTrading
Chimerix initiated with a Buy at JonesTrading
CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

CMRX Chimerix
$3.42 /

+0.18 (+5.56%)

Hot Stocks
Marriott expects COVID-19 'will continue to be material' to results » 07:25
08/10/20
08/10
07:25
08/10/20
07:25
MAR

Marriott

$93.80 /

+3.41 (+3.77%)

The company stated,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

07/02/20 Citi
Marriott price target raised to $95 from $75 at Citi
06/25/20 Gordon Haskett
Marriott initiated with a Hold at Gordon Haskett
06/23/20 Nomura Instinet
Marriott price target raised to $148 from $123 at Nomura Instinet
06/22/20 Barclays
Barclays turns positive on lodging, upgrades Marriott to Overweight
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

Hot Stocks
Amicus announces 2020 key strategic priorities » 07:23
08/10/20
08/10
07:23
08/10/20
07:23
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

Achieve $250 million to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Hot Stocks
Phoenix New Media enters into share repurchase agreement with Run Liang » 07:23
08/10/20
08/10
07:23
08/10/20
07:23
FENG

Phoenix New Media

$1.50 /

+ (+0.00%)

Phoenix New Media…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FENG Phoenix New Media
$1.50 /

+ (+0.00%)

Hot Stocks
Amicus sees cash position funding operations through to profitability » 07:23
08/10/20
08/10
07:23
08/10/20
07:23
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

Cash, cash equivalents,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Earnings
Amicus sees 2020 Galafold revenue $250M-$260M, consensus $254.82M  07:22
08/10/20
08/10
07:22
08/10/20
07:22
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

 
ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Initiation
GoHealth initiated with an Outperform at Evercore ISI » 07:22
08/10/20
08/10
07:22
08/10/20
07:22
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

07:21 Today Truist
GoHealth initiated with a Buy at Truist
06:48 Today RBC Capital
GoHealth initiated with an Outperform at RBC Capital
06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Earnings
Amicus reports Q2 EPS (20c), consensus (26c) » 07:22
08/10/20
08/10
07:22
08/10/20
07:22
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Initiation
GoHealth initiated with a Buy at Truist » 07:21
08/10/20
08/10
07:21
08/10/20
07:21
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

Truist analyst Tobey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

06:48 Today RBC Capital
GoHealth initiated with an Outperform at RBC Capital
06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
06:24 Today BofA
GoHealth initiated with a Buy at BofA
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Hot Stocks
TG Therapeutics announces key objectives for 2020, early 2021 » 07:21
08/10/20
08/10
07:21
08/10/20
07:21
TGTX

TG Therapeutics

$20.96 /

+0.15 (+0.72%)

Report topline results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

06/12/20 H.C. Wainwright
TG Therapeutics data presentations at EHA 'compelling,' says H.C. Wainwright
05/18/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/17/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/06/20 Cantor Fitzgerald
TG Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

  • 15
    May
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

Hot Stocks
TG Therapeutics expects cash to fund operations through the end of 2021 » 07:20
08/10/20
08/10
07:20
08/10/20
07:20
TGTX

TG Therapeutics

$20.96 /

+0.15 (+0.72%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

06/12/20 H.C. Wainwright
TG Therapeutics data presentations at EHA 'compelling,' says H.C. Wainwright
05/18/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/17/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/06/20 Cantor Fitzgerald
TG Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

  • 15
    May
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

Earnings
TG Therapeutics reports Q2 EPS (47c), consensus (34c) » 07:20
08/10/20
08/10
07:20
08/10/20
07:20
TGTX

TG Therapeutics

$20.96 /

+0.15 (+0.72%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

06/12/20 H.C. Wainwright
TG Therapeutics data presentations at EHA 'compelling,' says H.C. Wainwright
05/18/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/17/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/06/20 Cantor Fitzgerald
TG Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

  • 15
    May
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

Recommendations
Nvidia price target raised to $520 from $460 at BofA » 07:19
08/10/20
08/10
07:19
08/10/20
07:19
NVDA

Nvidia

$448.07 /

-5.355 (-1.18%)

BofA analyst Vivek Arya…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

08/03/20 Morgan Stanley
Synergies unclear if Nvidia buys controlling ARM interest, says Morgan Stanley
07/24/20 Raymond James
Intel 7nm delay positive for AMD, TSMC, Nvidia, says Raymond James
07/24/20 BMO Capital
Intel price target lowered to $50 from $55 at BMO Capital
07/14/20 Cowen
Nvidia price target raised to $475 from $410 at Cowen
NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

Initiation
nCino initiated with a Buy at Truist » 07:18
08/10/20
08/10
07:18
08/10/20
07:18
NCNO

nCino

$75.71 /

+0.21 (+0.28%)

Truist analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$75.71 /

+0.21 (+0.28%)

06:59 Today Raymond James
nCino initiated with a Market Perform at Raymond James
06:57 Today KeyBanc
KeyBanc bullish on nCino, initiates with an Overweight
06:19 Today BofA
nCino initiated with a Buy at BofA
06:14 Today Piper Sandler
nCino initiated with an Overweight at Piper Sandler
  • 14
    Jul
NCNO nCino
$75.71 /

+0.21 (+0.28%)

NCNO nCino
$75.71 /

+0.21 (+0.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.